| Theresa Castro Toledo, MD | |
|
5500 Auto Club Dr, Dearborn, MI 48126 | |
| (313) 425-4500 | |
| Not Available |
| Full Name | Theresa Castro Toledo |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 12 Years |
| Location | 5500 Auto Club Dr, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477962884 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 4301106359 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Quanterix announce the closing of its previously announced underwritten public offering of 2,732,673 shares of its common stock.
The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.
A 49-year-old male with a history of COVID-19 presents with tinnitus.
› Verified 8 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Quanterix announce the closing of its previously announced underwritten public offering of 2,732,673 shares of its common stock.
The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.
A 49-year-old male with a history of COVID-19 presents with tinnitus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Castro Toledo, MD 5500 Auto Club Dr, Dearborn, MI 48126-2779 Ph: (313) 317-2000 | Theresa Castro Toledo, MD 5500 Auto Club Dr, Dearborn, MI 48126 Ph: (313) 425-4500 |
News Archive
To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
Quanterix announce the closing of its previously announced underwritten public offering of 2,732,673 shares of its common stock.
The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.
A 49-year-old male with a history of COVID-19 presents with tinnitus.
› Verified 8 days ago
Nathan Lwo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Parthkumar Patel, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dora Mell, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Ethan Aleksandr Bork, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Suheb Mashkoor Hasan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3815 Pelham St, Ste 1, Dearborn, MI 48124 Phone: 313-593-3915 Fax: 313-792-8812 | |
Dr. Hassan Mohamed Barade, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Manuel Dumlao, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2314 Monroe St, Dearborn, MI 48124 Phone: 313-562-6633 Fax: 313-562-0880 |